99 related articles for article (PubMed ID: 20652946)
1. IL-13 upregulates GPIIb expression in megakaryocytic cell lines via STAT6.
Shi X; Cai W; Zhou Y; Zhang X; Xiong L; Li R; Yu X; Li W
Anat Rec (Hoboken); 2010 Sep; 293(9):1470-6. PubMed ID: 20652946
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
[TBL] [Abstract][Full Text] [Related]
3. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
[TBL] [Abstract][Full Text] [Related]
4. Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells.
Tian C; Kron GK; Dischert KM; Higginbotham JN; Crowe JE
Immunology; 2006 Sep; 119(1):54-62. PubMed ID: 16764687
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
[TBL] [Abstract][Full Text] [Related]
6. [Effects of interleukin 13 on the differentiation and expression of transcription factor c-fos of HEL cells].
Shi XY; Yu XM; Li WL; Wang ZG; Tang HL; Zhang XJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):538-42. PubMed ID: 17172128
[TBL] [Abstract][Full Text] [Related]
7. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription 6 down-regulates toll-like receptor-4 expression of a monocytic cell line.
Fiset PO; Tulic MK; Skrablin PS; Grover SM; Létuvé S; Mazer BD; Hamid Q
Clin Exp Allergy; 2006 Feb; 36(2):158-65. PubMed ID: 16433852
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB.
Kobayashi I; Yamamoto S; Nishi N; Tsuji K; Imayoshi M; Inada S; Ichiamaru T; Hamasaki Y
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):390-7. PubMed ID: 15521376
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IL-13 receptor alpha 1 expression and signaling on human tonsillar B-lymphocyte subsets.
Hajoui O; Zheng H; Guay J; Letuve S; Fawaz LM; Mazer BD
J Allergy Clin Immunol; 2007 Dec; 120(6):1425-32. PubMed ID: 17761275
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells.
Arinobu Y; Sugimoto R; Akaiwa M; Arima K; Otsuka T; Hamasaki N; Izuhara K
Biochem Biophys Res Commun; 2000 Oct; 277(2):317-24. PubMed ID: 11032724
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism.
Matsukura S; Stellato C; Georas SN; Casolaro V; Plitt JR; Miura K; Kurosawa S; Schindler U; Schleimer RP
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):755-61. PubMed ID: 11415942
[TBL] [Abstract][Full Text] [Related]
13. Flavones suppress type I IL-4 receptor signaling by down-regulating the expression of common gamma chain.
Yamashita S; Yamashita T; Yamada K; Tachibana H
FEBS Lett; 2010 Feb; 584(4):775-9. PubMed ID: 20040389
[TBL] [Abstract][Full Text] [Related]
14. STAT-1 is activated by IL-4 and IL-13 in multiple cell types.
Wang IM; Lin H; Goldman SJ; Kobayashi M
Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts.
Fukuda K; Fujitsu Y; Kumagai N; Nishida T
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):183-8. PubMed ID: 11773030
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle IL-4, IL-4Ralpha, IL-13 and IL-13Ralpha1 expression and response to strength training.
Prokopchuk O; Liu Y; Wang L; Wirth K; Schmidtbleicher D; Steinacker JM
Exerc Immunol Rev; 2007; 13():67-75. PubMed ID: 18198661
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines.
Navarro S; Mitjavila MT; Katz A; Doly J; Vainchenker W
Exp Hematol; 1991 Jan; 19(1):11-7. PubMed ID: 1989890
[TBL] [Abstract][Full Text] [Related]
18. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
[TBL] [Abstract][Full Text] [Related]
19. Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells.
Saleh A; Shan L; Halayko AJ; Kung S; Gounni AS
J Immunol; 2009 Mar; 182(6):3357-65. PubMed ID: 19265112
[TBL] [Abstract][Full Text] [Related]
20. Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines.
Myrtek D; Knoll M; Matthiesen T; Krause S; Lohrmann J; Schillinger D; Idzko M; Virchow JC; Friedrich K; Luttmann W
Immunology; 2004 Aug; 112(4):597-604. PubMed ID: 15270731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
